Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Molecular Brain Research
- Vol. 3 (1), 31-37
- https://doi.org/10.1016/0169-328x(87)90041-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the ratBrain Research, 1986
- The localization and characterization of substance P and substance K in striatonigral neuronsBrain Research, 1986
- Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicingNature, 1984
- Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance PEuropean Journal of Pharmacology, 1984
- Substance P immunoreactivity in the post-mortem parkinsonian brainBrain Research, 1984
- Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursorNature, 1983
- Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brainsBrain Research, 1983
- Response of striatonigral substance P systems to a dopamine receptor agonist and antagonistNeuropharmacology, 1981
- D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamineBrain Research, 1980
- Substance P content of substantia nigra after chronic treatment with antischizophrenic drugsNeuropharmacology, 1978